Peptides having antiangiogenic activity

   
   

Peptides of formula (I) Xaa.sub.1 -Xaa.sub.2 -Xaa.sub.3 -Xaa.sub.4 -Xaa.sub.5 -Xaa.sub.6 -Xaa.sub.7 -Xaa.sub.8 -Xaa.sub.9 -Xaa.sub.10 -Xaa.sub.11 (I), are useful for inhibiting angiogenesis. Also disclosed are angiogenesis-inhibiting compositions and methods of inhibiting angiogenesis in a mammal.

Peptidi della formula (i) Xaa.sub.1 - Xaa.sub.2 - Xaa.sub.3 - Xaa.sub.4 - Xaa.sub.5 - Xaa.sub.6 - Xaa.sub.7 - Xaa.sub.8 - Xaa.sub.9 - Xaa.sub.10 - Xaa.sub.11 (i), sono utili per l'inibizione del angiogenesis. Inoltre rilevato angiogenesis-stanno inibendo le composizioni ed i metodi di inibizione del angiogenesis in un mammifero.

 
Web www.patentalert.com

< Pyrimidine A2b selective antagonist compounds, their synthesis and use

< Methods of treating disorders with Group I mGluR antagonists

> Benzoxazines for use in the treatment of parkinson's disease

> Prevention and treatment of degenerative diseases by glutathione and phase II detoxification enzymes

~ 00117